Al­most half of all new drug ap­provals in 2018 re­lied on one clin­i­cal tri­al

Back in the 1970s and 1980s, the FDA made clear that at least two ad­e­quate and well-con­trolled stud­ies were nec­es­sary to es­tab­lish a new drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.